ELREXFIO
As listed in the register: ELREXFIO 40 MG/ML SOLUCION INYECTABLE
40 mg/ml · solución inyectable
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Elranatamab
- Made by
- Pfizer Europe Ma Eeig
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands1 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pfizer Europe Ma Eeig |
|---|---|
| Active substance | Elranatamab |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 40 mg/ml |
| Form | solución inyectable |
| Classification | L01FX32 · Cancer treatments and immune-system medicines |
| Route | vía subcutánea |
| Marketed | Yes, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | ELREXFIO 40 MG/ML SOLUCION INYECTABLE |
| Nº Registro | 1231770001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.